New heart pump takes on impella in High-Stakes stenting trial
NCT ID NCT07296744
First seen Jan 07, 2026
Summary
This study compares a new temporary heart pump called the Supira System to the existing Impella pump in 358 patients undergoing high-risk coronary stenting. The goal is to see if Supira is as safe and effective at supporting the heart during the procedure. Participants are randomly assigned to receive one of the two pumps.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor Scott & White The Heart Hospital
NOT_YET_RECRUITINGPlano, Texas, 75093, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CentraCare
RECRUITINGSaint Cloud, Minnesota, 56362, United States
Contact
Contact
-
Cuimc/Nyph
RECRUITINGNew York, New York, 10032, United States
Contact
Contact
Contact
-
Emory University Hospital
NOT_YET_RECRUITINGAtlanta, Georgia, 30322, United States
Contact Email: •••••@•••••
Contact
-
Henry Ford Health / St. John Hospital
RECRUITINGDetroit, Michigan, 48236, United States
Contact
Contact
-
Montefiore Medical Center
RECRUITINGThe Bronx, New York, 10467, United States
Contact
Contact
-
OhioHealth
RECRUITINGColumbus, Ohio, 43214, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Oklahoma Heart Hillcrest Medical
RECRUITINGTulsa, Oklahoma, 74104, United States
Contact
Contact
-
Piedmont Heart Institute
RECRUITINGAtlanta, Georgia, 30309, United States
Contact
Contact
-
Prisma Health
NOT_YET_RECRUITINGColumbia, South Carolina, 29203, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
UC Davis
RECRUITINGSacramento, California, 95817, United States
Contact
Contact
-
University of Buffalo (Buffalo General)
NOT_YET_RECRUITINGBuffalo, New York, 14203, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Washington University in St. Louis
RECRUITINGSt Louis, Missouri, 63110, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Wellspan York Hospital
RECRUITINGYork, Pennsylvania, 17403, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Supira System (temporary heart pump device)
What this could lead to
If it works, this could offer a safer or more effective temporary heart support option during high-risk stenting procedures.
What could go wrong
This is a relatively early-stage device trial with 358 participants, so results may not apply to all patients. There are risks like bleeding, stroke, or kidney injury common to these procedures.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.